Narcan Spray
Product Images NDC 50090-2422

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Narcan (NDC 50090-2422). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500902422)

NARCAN Naloxone Hydrochloride Nasal Spray packaging label from A-S Medication Solutions. The label shows product details including the strength of 4 mg/0.1 mL per spray, lot number, storage instructions to keep at 40 degrees Fahrenheit or below and to protect from light, and package insert information. The product is distributed by A-S Medication Solutions in Libertyville, Illinois, and contains 2 units per box.*

FDA Label Image

Narcan 01

Chemical structure diagram of Naloxone Hydrochloride, the active ingredient in NARCAN nasal spray. The structure shows its molecular components and bonds including a hydrochloride component (HCl).*

FDA Label Image

Narcan 02

This chart illustrates naloxone plasma concentration (mg/mL) over time (hours postdose) for various dosing regimens including 2 mg and 4 mg nasal sprays with different spray counts per nostril, 8 mg nasal spray, and 0.4 mg intramuscular injection. It compares plasma levels across these treatments up to 6 hours after dosing.*

FDA Label Image

Narcan 03

A line graph depicting naloxone plasma concentration (ng/mL) over time in hours postdose. The graph compares different dosages and administration routes of naloxone, including 2 mg and 4 mg nasal sprays at different concentrations and nostrils, as well as an 0.4 mg intramuscular injection. Each line represents a different regimen, showing plasma naloxone levels from 0 to 1 hour after dosing, with error bars indicating variability.*

FDA Label Image

Narcan 04

Illustration showing hands peeling open a foil packet labeled Narcan Nasal Spray. The image demonstrates how to remove the Narcan Nasal Spray from its packaging before use.*

FDA Label Image

Narcan 05

An illustrative diagram showing a hand holding a nasal spray device labeled with the nozzle and plunger components. The image depicts proper handling of the spray for administration, related to NARCAN nasal spray (Naloxone Hydrochloride).*

FDA Label Image

Narcan 06

An instructional illustration showing a person receiving a nasal spray. The spray is being administered into one nostril while the other hand supports the head, demonstrating proper use technique for a nasal spray product like NARCAN nasal spray.*

FDA Label Image

Narcan 07

An instructional illustration showing the use of a nasal spray being administered into a person's nostril. The image depicts a hand holding the spray device aimed at the nasal passage, with visible spray droplets indicating the delivery method.*

FDA Label Image

Narcan 08

An instructional diagram showing a person positioned on their side with the head supported by a hand. The illustration includes labels indicating the hand supports the head and the knee stops the body from rolling onto the stomach.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.